KLH-2109

· Kissei Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for KLH-2109, covering 2013-10-30 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of KLH-2109 in Patients With Endometriosis [Phase 3]